Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
28,032,706
-
Shares change
-
+4,157,389
-
Total reported value, excl. options
-
$282,560,154
-
Value change
-
+$33,018,222
-
Put/Call ratio
-
44%
-
Number of buys
-
42
-
Number of sells
-
-39
-
Price
-
$10.08
Significant Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q3 2015
99 filings reported holding TGTX - TG THERAPEUTICS, INC. - COMMON STOCK as of Q3 2015.
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28,032,706 shares
of 158,835,667 outstanding shares and own 18% of the company stock.
Largest 10 shareholders include FMR LLC (5,963,301 shares), RA CAPITAL MANAGEMENT, LLC (3,124,480 shares), BRIDGER MANAGEMENT, LLC (3,053,916 shares), STATE STREET CORP (2,635,023 shares), BAKER BROS. ADVISORS LP (2,003,991 shares), Sectoral Asset Management Inc (1,464,105 shares), VANGUARD GROUP INC (1,222,023 shares), BlackRock Fund Advisors (932,054 shares), BlackRock Institutional Trust Company, N.A. (868,096 shares), and COLUMBUS CIRCLE INVESTORS (661,199 shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.